Syngenta snaps up U.S. biotech company Pasteuria
ZURICH, Sept 19
ZURICH, Sept 19 (Reuters) - The world's largest agribusiness company Syngenta said on Wednesday it will acquire U.S. biotech company Pasteuria Bioscience Inc in a deal worth $86 million, with additional deferred payments of up to $27 million.
The two companies already collaborate in the development and commercialization of biological products to control plant-parasitic nematodes.
Nematodes are a major pest across all crops and the withdrawal of older solutions leaves growers with limited options.
A first seed treatment for soybean cyst nematode stemming from the collaboration will be available in the U.S. in 2014, Syngenta said.
(by Andrew Thompson)
- Tweet this
- Share this
- Digg this
- Housing data hits Wall Street; S&P has worst day since August 5 |
- Housing data hits Wall St; S&P has worst day since Aug 5
- CANADA STOCKS-TSX hits six-week low on China fears, commodity prices
- India's Mars mission a step closer to success with engine test
- U.S. SEC to pay $30 million-plus in largest whistleblower award